509 related articles for article (PubMed ID: 26754641)
1. Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status.
Piccio L; Deming Y; Del-Águila JL; Ghezzi L; Holtzman DM; Fagan AM; Fenoglio C; Galimberti D; Borroni B; Cruchaga C
Acta Neuropathol; 2016 Jun; 131(6):925-33. PubMed ID: 26754641
[TBL] [Abstract][Full Text] [Related]
2. The
Deming Y; Filipello F; Cignarella F; Cantoni C; Hsu S; Mikesell R; Li Z; Del-Aguila JL; Dube U; Farias FG; Bradley J; Budde J; Ibanez L; Fernandez MV; Blennow K; Zetterberg H; Heslegrave A; Johansson PM; Svensson J; Nellgård B; Lleo A; Alcolea D; Clarimon J; Rami L; Molinuevo JL; Suárez-Calvet M; Morenas-Rodríguez E; Kleinberger G; Ewers M; Harari O; Haass C; Brett TJ; Benitez BA; Karch CM; Piccio L; Cruchaga C
Sci Transl Med; 2019 Aug; 11(505):. PubMed ID: 31413141
[TBL] [Abstract][Full Text] [Related]
3. TREM2 brain transcript-specific studies in AD and TREM2 mutation carriers.
Del-Aguila JL; Benitez BA; Li Z; Dube U; Mihindukulasuriya KA; Budde JP; Farias FHG; Fernández MV; Ibanez L; Jiang S; Perrin RJ; Cairns NJ; Morris JC; Harari O; Cruchaga C
Mol Neurodegener; 2019 May; 14(1):18. PubMed ID: 31068200
[TBL] [Abstract][Full Text] [Related]
4. Variants in the MS4A cluster interact with soluble TREM2 expression on biomarkers of neuropathology.
Winfree RL; Nolan E; Dumitrescu L; Blennow K; Zetterberg H; Gifford KA; Pechman KR; Seto M; Petyuk VA; Wang Y; Schneider J; Bennett DA; Jefferson AL; Hohman TJ;
Mol Neurodegener; 2024 May; 19(1):41. PubMed ID: 38760857
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid soluble TREM2 in aging and Alzheimer's disease.
Henjum K; Almdahl IS; Årskog V; Minthon L; Hansson O; Fladby T; Nilsson LN
Alzheimers Res Ther; 2016 Apr; 8(1):17. PubMed ID: 27121148
[TBL] [Abstract][Full Text] [Related]
6. Proteo-genomics of soluble TREM2 in cerebrospinal fluid provides novel insights and identifies novel modulators for Alzheimer's disease.
Wang L; Nykänen NP; Western D; Gorijala P; Timsina J; Li F; Wang Z; Ali M; Yang C; Liu M; Brock W; Marquié M; Boada M; Alvarez I; Aguilar M; Pastor P; Ruiz A; Puerta R; Orellana A; Rutledge J; Oh H; Greicius MD; Le Guen Y; Perrin RJ; Wyss-Coray T; Jefferson A; Hohman TJ; Graff-Radford N; Mori H; Goate A; Levin J; Sung YJ; Cruchaga C
Mol Neurodegener; 2024 Jan; 19(1):1. PubMed ID: 38172904
[TBL] [Abstract][Full Text] [Related]
7. CSF soluble TREM2 as a measure of immune response along the Alzheimer's disease continuum.
Rauchmann BS; Schneider-Axmann T; Alexopoulos P; Perneczky R;
Neurobiol Aging; 2019 Feb; 74():182-190. PubMed ID: 30458365
[TBL] [Abstract][Full Text] [Related]
8. TREM2 splice isoforms generate soluble TREM2 species that disrupt long-term potentiation.
Moutinho M; Coronel I; Tsai AP; Di Prisco GV; Pennington T; Atwood BK; Puntambekar SS; Smith DC; Martinez P; Han S; Lee Y; Lasagna-Reeves CA; Lamb BT; Bissel SJ; Nho K; Landreth GE
Genome Med; 2023 Feb; 15(1):11. PubMed ID: 36805764
[TBL] [Abstract][Full Text] [Related]
9. Defects in lysosomal function and lipid metabolism in human microglia harboring a TREM2 loss of function mutation.
Filipello F; You SF; Mirfakhar FS; Mahali S; Bollman B; Acquarone M; Korvatska O; Marsh JA; Sivaraman A; Martinez R; Cantoni C; De Feo L; Ghezzi L; Minaya MA; Renganathan A; Cashikar AG; Satoh JI; Beatty W; Iyer AK; Cella M; Raskind WH; Piccio L; Karch CM
Acta Neuropathol; 2023 Jun; 145(6):749-772. PubMed ID: 37115208
[TBL] [Abstract][Full Text] [Related]
10. Biological correlates of elevated soluble TREM2 in cerebrospinal fluid.
Winfree RL; Dumitrescu L; Blennow K; Zetterberg H; Gifford KA; Pechman KR; Jefferson AL; Hohman TJ;
Neurobiol Aging; 2022 Oct; 118():88-98. PubMed ID: 35908327
[TBL] [Abstract][Full Text] [Related]
11. Computational saturation mutagenesis to explore the effect of pathogenic mutations on extra-cellular domains of TREM2 associated with Alzheimer's and Nasu-Hakola disease.
Swain PS; Panda S; Pati S; Dehury B
J Mol Model; 2023 Nov; 29(11):360. PubMed ID: 37924367
[TBL] [Abstract][Full Text] [Related]
12. Microglial Reactivity Correlates with Presynaptic Loss Independent of β-Amyloid and Tau.
Lan G; Chen X; Yang J; Sun P; Cai Y; Li A; Zhu Y; Liu Z; Ma S; Guo T;
Ann Neurol; 2024 May; 95(5):917-928. PubMed ID: 38356322
[TBL] [Abstract][Full Text] [Related]
13. R47H TREM2 variant increases risk of typical early-onset Alzheimer's disease but not of prion or frontotemporal dementia.
Slattery CF; Beck JA; Harper L; Adamson G; Abdi Z; Uphill J; Campbell T; Druyeh R; Mahoney CJ; Rohrer JD; Kenny J; Lowe J; Leung KK; Barnes J; Clegg SL; Blair M; Nicholas JM; Guerreiro RJ; Rowe JB; Ponto C; Zerr I; Kretzschmar H; Gambetti P; Crutch SJ; Warren JD; Rossor MN; Fox NC; Collinge J; Schott JM; Mead S
Alzheimers Dement; 2014 Nov; 10(6):602-608.e4. PubMed ID: 25160042
[TBL] [Abstract][Full Text] [Related]
14. Examination of the Effect of Rare Variants in TREM2, ABI3, and PLCG2 in LOAD Through Multiple Phenotypes.
Olive C; Ibanez L; Farias FHG; Wang F; Budde JP; Norton JB; Gentsch J; Morris JC; Li Z; Dube U; Del-Aguila J; Bergmann K; Bradley J; Benitez BA; Harari O; Fagan A; Ances B; Cruchaga C; Fernandez MV
J Alzheimers Dis; 2020; 77(4):1469-1482. PubMed ID: 32894242
[TBL] [Abstract][Full Text] [Related]
15. Trem2 Y38C mutation and loss of Trem2 impairs neuronal synapses in adult mice.
Jadhav VS; Lin PBC; Pennington T; Di Prisco GV; Jannu AJ; Xu G; Moutinho M; Zhang J; Atwood BK; Puntambekar SS; Bissel SJ; Oblak AL; Landreth GE; Lamb BT
Mol Neurodegener; 2020 Oct; 15(1):62. PubMed ID: 33115519
[TBL] [Abstract][Full Text] [Related]
16. Soluble TREM2 ameliorates tau phosphorylation and cognitive deficits through activating transgelin-2 in Alzheimer's disease.
Zhang X; Tang L; Yang J; Meng L; Chen J; Zhou L; Wang J; Xiong M; Zhang Z
Nat Commun; 2023 Oct; 14(1):6670. PubMed ID: 37865646
[TBL] [Abstract][Full Text] [Related]
17. An Altered Relationship between Soluble TREM2 and Inflammatory Markers in Young Adults with Down Syndrome: A Preliminary Report.
Weber GE; Koenig KA; Khrestian M; Shao Y; Tuason ED; Gramm M; Lal D; Leverenz JB; Bekris LM
J Immunol; 2020 Mar; 204(5):1111-1118. PubMed ID: 31959733
[TBL] [Abstract][Full Text] [Related]
18. Peripheral sTREM2-Related Inflammatory Activity Alterations in Early-Stage Alzheimer's Disease.
Weber GE; Khrestian M; Tuason ED; Shao Y; Pillai J; Rao S; Feng H; Zhou Y; Cheng F; DeSilva TM; Stauffer S; Leverenz JB; Bekris LM
J Immunol; 2022 May; 208(10):2283-2299. PubMed ID: 35523454
[TBL] [Abstract][Full Text] [Related]
19. Soluble TREM2 triggers microglial dysfunction in neuromyelitis optica spectrum disorders.
Qin C; Chen M; Dong MH; Yang S; Zhang H; You YF; Zhou LQ; Chu YH; Tang Y; Pang XW; Wu LJ; Tian DS; Wang W
Brain; 2024 Jan; 147(1):163-176. PubMed ID: 37740498
[TBL] [Abstract][Full Text] [Related]
20. Association of soluble TREM2 with Alzheimer's disease and mild cognitive impairment: a systematic review and meta-analysis.
Wang R; Zhan Y; Zhu W; Yang Q; Pei J
Front Aging Neurosci; 2024; 16():1407980. PubMed ID: 38841103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
